PPD-specific IgG1 antibody subclass upregulate tumour necrosis factor expression in PPD-stimulated monocytes: Possible link with disease pathogenesis in tuberculosis

Clinical and Experimental Immunology

Volumn 119, Issue 3, 2000, Pages 449-455

  Hussain, R ^a   Shiratsuchi, H ^b   Ellner, J J ^b   Wallis, R S ^b  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody subclasses; Cytokines; IgG; Monocyte; TNF ; Tuberculosis

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; MANNOSE; PROTEIN A; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY DETECTION; ARTICLE; CACHEXIA; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; OPSONIZATION; PRIORITY JOURNAL; REGULATORY MECHANISM; TUBERCULOSIS;

CELLS, CULTURED; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MONOCYTES; TUBERCULIN; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0034063324     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 1 Schlesinger LS. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993; 150:2920-30.
2. 2 Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptor C3. J Immunol 1990; 144:2771-80.
3. 3 Huber HS, Douglas D, Nusbacher J, Kochwa S, Rosenfield RE. IgG subclass specificity of human monocyte receptor sites. Nature 1971; 229:419-20.
4. 4 Hussain R, Kifayet A, Chiang TJ. Immunologulin G (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy. Infect Immun 1995; 63:410-5.
5. 5 Hussain R, Dawood G, Abrar N, Toossi Z, Minai A, Dojki M. Ellner JJ. Selective increases in antibody isotypes and IgG subclass responses to secreted antigens in tuberculosis patients and household contacts. Clin Diagn Lab Immunol 1995; 2:726-32.
6. 6 Shakib F, ed. Basic and clinical aspects of IgG subclasses. New York: S. Karger Publications, 1986.
7. 7 Beutler B, Mahoney LeTrang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264-cells. J Exp Med 1985; 161:984-95.
8. 8 Dinarello CA, Cannon JG, Wolff SM et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163:1433-50.
9. 9 Pisa P, Gennene M, Soder O, Ottenhoff T, Hansson M, Kiessling R. Scrum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis. J Inf Dis 1990; 161:988-91.
10. 10 Santos D, Suffys O, Bonifacio PN, Marques K, Sarno EN. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum. Clin Imm Immunopathol 1993; 67:199-203.
11. 11 Barnes PF, Chatterjee D, Brennan PJ, Rea TH, Modlin RL. Tumor necrosis factor production in patients with leprosy. Infect Immun 1992; 60:1441-6.
12. 12 Friedland JS, Hartley JC, Hartley CGC, Shattock RJ, Griffin GE. Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis. Infect Clin Exp Immunol 1995; 100:233-8.
13. 13 Valone SE, Rich EA, Wallis RS, Ellner JJ. Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with while Mycobacterium bovis BCG and Mycobacterial antigens. Infect Immun 1988; 56:3313-5.
14. 14 Wallis RS, Amir-Tahmesseb M, Ellner JJ. Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte Western blot. PNAS 1990; 87:3348-52.
15. 15 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
16. 16 Hussain R, Hasan R, Khurshid M, Sturm AW, Ellner JJ, Dawood G. Pulmonary tuberculosis in a BCG vaccinated area: relationship of disease severity with immunological and haematological parameters and drug resistance patterns. SE Asian J Trop Med Pub Health 1996; 27:257-62.
17. 17 Hussain R, Poindexter RW, Wistar R, Reimer CB. Use of monoclonal antibodies to quantify subclasses of human IgG. I. Development of two site immuno enzymometric assays for total IgG subclass determinations. J Immunol Meth 1986; 93:89-96.
18. 18 Hussain R, Poindexter RW, Reimer CB. Use of monoclonal antibodies to quantify subclasses of human IgG. II. Enzyme immunoassay to define filaria specific IgG subclass antibodies. J Immunol Meth 1986; 94:73-80.
19. 19 Feinstein A et al. IgG flexibility in complement activation. Immunol Today 1986; 7:169.
20. 20 Hjelm H, Hjelm K, Sjoquist J. Protein 'A' from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins. FEBS Lett 1972; 28:73-6.
21. 21 Recht B, Frangione B, Franklin E, van Loghem E. Structural studies of a human 3 myeloma protein (GOE) that binds to Staph protein A. J Immunol 1981; 127:917-23.